The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Insomnia is a sleep disorder where people have trouble sleeping. They may have difficulty falling asleep, or staying asleep as long as desired. Insomnia is typically followed by daytime sleepiness, low energy, irritability, and a depressed mood.
The global Insomnia market size is expected to reach US$ 5074.9 million by 2029, growing at a CAGR of 3.4% from 2023 to 2029. The market is mainly driven by the significant applications of Insomnia in various end use industries. The expanding demands from the Female, Male and Senior Citizens,, are propelling Insomnia market. Pharmacological Therapy, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Non-pharmacological Therapy segment is estimated at % CAGR for the next seven-year period.
Sleep hygiene and lifestyle changes are typically the first treatment for insomnia. Sleep hygiene includes a consistent bedtime, exposure to sunlight, a quiet and dark room, and regular exercise. Cognitive behavioral therapy may be added to this. While sleeping pills may help, they are associated with injuries, dementia, and addiction.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Insomnia, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Insomnia market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Insomnia market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Insomnia sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Insomnia covered in this report include Merck, Eisai, Meda Consumer Healthcare, Takeda Pharmaceuticals, Pfizer, Sanofi, Vanda Pharmaceuticals, Pernix Therapeutics and Purdue Pharmaceuticals, etc.
The global Insomnia market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
- Merck
- Eisai
- Meda Consumer Healthcare
- Takeda Pharmaceuticals
- Pfizer
- Sanofi
- Vanda Pharmaceuticals
- Pernix Therapeutics
- Purdue Pharmaceuticals
Global Insomnia market, by region:
- North America (U.S., Canada, Mexico)
- Europe (Germany, France, UK, Italy, etc.)
- Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
- South America (Brazil, etc.)
- Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Insomnia market, Segment by Type:
- Pharmacological Therapy
- Non-pharmacological Therapy
Global Insomnia market, by Application:
- Female
- Male
- Senior Citizens
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Insomnia companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index
1 Market Overview of Insomnia
1.1 Insomnia Market Overview
1.1.1 Insomnia Product Scope
1.1.2 Insomnia Market Status and Outlook
1.2 Global Insomnia Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Insomnia Market Size by Region (2018-2029)
1.4 Global Insomnia Historic Market Size by Region (2018-2023)
1.5 Global Insomnia Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Insomnia Market Size (2018-2029)
1.6.1 North America Insomnia Market Size (2018-2029)
1.6.2 Europe Insomnia Market Size (2018-2029)
1.6.3 Asia-Pacific Insomnia Market Size (2018-2029)
1.6.4 Latin America Insomnia Market Size (2018-2029)
1.6.5 Middle East & Africa Insomnia Market Size (2018-2029)
2 Insomnia Market by Type
2.1 Introduction
2.1.1 Pharmacological Therapy
2.1.2 Non-pharmacological Therapy
2.2 Global Insomnia Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Insomnia Historic Market Size by Type (2018-2023)
2.2.2 Global Insomnia Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Insomnia Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Insomnia Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Insomnia Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Insomnia Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Insomnia Revenue Breakdown by Type (2018-2029)
3 Insomnia Market Overview by Application
3.1 Introduction
3.1.1 Female
3.1.2 Male
3.1.3 Senior Citizens
3.2 Global Insomnia Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Insomnia Historic Market Size by Application (2018-2023)
3.2.2 Global Insomnia Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Insomnia Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Insomnia Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Insomnia Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Insomnia Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Insomnia Revenue Breakdown by Application (2018-2029)
4 Insomnia Competition Analysis by Players
4.1 Global Insomnia Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Insomnia as of 2022)
4.3 Date of Key Players Enter into Insomnia Market
4.4 Global Top Players Insomnia Headquarters and Area Served
4.5 Key Players Insomnia Product Solution and Service
4.6 Competitive Status
4.6.1 Insomnia Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Merck
5.1.1 Merck Profile
5.1.2 Merck Main Business
5.1.3 Merck Insomnia Products, Services and Solutions
5.1.4 Merck Insomnia Revenue (US$ Million) & (2018-2023)
5.1.5 Merck Recent Developments
5.2 Eisai
5.2.1 Eisai Profile
5.2.2 Eisai Main Business
5.2.3 Eisai Insomnia Products, Services and Solutions
5.2.4 Eisai Insomnia Revenue (US$ Million) & (2018-2023)
5.2.5 Eisai Recent Developments
5.3 Meda Consumer Healthcare
5.3.1 Meda Consumer Healthcare Profile
5.3.2 Meda Consumer Healthcare Main Business
5.3.3 Meda Consumer Healthcare Insomnia Products, Services and Solutions
5.3.4 Meda Consumer Healthcare Insomnia Revenue (US$ Million) & (2018-2023)
5.3.5 Takeda Pharmaceuticals Recent Developments
5.4 Takeda Pharmaceuticals
5.4.1 Takeda Pharmaceuticals Profile
5.4.2 Takeda Pharmaceuticals Main Business
5.4.3 Takeda Pharmaceuticals Insomnia Products, Services and Solutions
5.4.4 Takeda Pharmaceuticals Insomnia Revenue (US$ Million) & (2018-2023)
5.4.5 Takeda Pharmaceuticals Recent Developments
5.5 Pfizer
5.5.1 Pfizer Profile
5.5.2 Pfizer Main Business
5.5.3 Pfizer Insomnia Products, Services and Solutions
5.5.4 Pfizer Insomnia Revenue (US$ Million) & (2018-2023)
5.5.5 Pfizer Recent Developments
5.6 Sanofi
5.6.1 Sanofi Profile
5.6.2 Sanofi Main Business
5.6.3 Sanofi Insomnia Products, Services and Solutions
5.6.4 Sanofi Insomnia Revenue (US$ Million) & (2018-2023)
5.6.5 Sanofi Recent Developments
5.7 Vanda Pharmaceuticals
5.7.1 Vanda Pharmaceuticals Profile
5.7.2 Vanda Pharmaceuticals Main Business
5.7.3 Vanda Pharmaceuticals Insomnia Products, Services and Solutions
5.7.4 Vanda Pharmaceuticals Insomnia Revenue (US$ Million) & (2018-2023)
5.7.5 Vanda Pharmaceuticals Recent Developments
5.8 Pernix Therapeutics
5.8.1 Pernix Therapeutics Profile
5.8.2 Pernix Therapeutics Main Business
5.8.3 Pernix Therapeutics Insomnia Products, Services and Solutions
5.8.4 Pernix Therapeutics Insomnia Revenue (US$ Million) & (2018-2023)
5.8.5 Pernix Therapeutics Recent Developments
5.9 Purdue Pharmaceuticals
5.9.1 Purdue Pharmaceuticals Profile
5.9.2 Purdue Pharmaceuticals Main Business
5.9.3 Purdue Pharmaceuticals Insomnia Products, Services and Solutions
5.9.4 Purdue Pharmaceuticals Insomnia Revenue (US$ Million) & (2018-2023)
5.9.5 Purdue Pharmaceuticals Recent Developments
6 North America
6.1 North America Insomnia Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Insomnia Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Insomnia Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Insomnia Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Insomnia Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Insomnia Market Dynamics
11.1 Insomnia Industry Trends
11.2 Insomnia Market Drivers
11.3 Insomnia Market Challenges
11.4 Insomnia Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
